Follow
JUANJUAN SU
JUANJUAN SU
Ph.D of Institute of Health Sciences, Shanghai Institutes for Biological Sciences, CAS, China
Verified email at cnmc.org
Title
Cited by
Cited by
Year
Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression
G Ren, J Su, L Zhang, X Zhao, W Ling, A L'huillie, J Zhang, Y Lu, ...
Stem cells 27 (8), 1954-1962, 2009
7502009
How mesenchymal stem cells interact with tissue immune responses
Y Shi, J Su, AI Roberts, P Shou, AB Rabson, G Ren
Trends in immunology 33 (3), 136-143, 2012
7092012
Mesenchymal stem cells: a new strategy for immunosuppression and tissue repair
Y Shi, G Hu, J Su, W Li, Q Chen, P Shou, C Xu, X Chen, Y Huang, Z Zhu, ...
Cell research 20 (5), 510-518, 2010
7042010
Mesenchymal stem cells: a double-edged sword in regulating immune responses
W Li, G Ren, Y Huang, J Su, Y Han, J Li, X Chen, K Cao, Q Chen, P Shou, ...
Cell Death & Differentiation 19 (9), 1505-1513, 2012
5032012
Phylogenetic distinction of iNOS and IDO function in mesenchymal stem cell-mediated immunosuppression in mammalian species
J Su, X Chen, Y Huang, W Li, J Li, K Cao, G Cao, L Zhang, F Li, ...
Cell Death & Differentiation 21 (3), 388-396, 2014
2592014
A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy
X Du, F Tang, M Liu, J Su, Y Zhang, W Wu, M Devenport, CA Lazarski, ...
Cell research 28 (4), 416-432, 2018
2292018
The interaction between mesenchymal stem cells and steroids during inflammation
X Chen, Y Gan, W Li, J Su, Y Zhang, Y Huang, AI Roberts, Y Han, J Li, ...
Cell death & disease 5 (1), e1009-e1009, 2014
1102014
Uncoupling therapeutic from immunotherapy-related adverse effects for safer and effective anti-CTLA-4 antibodies in CTLA4 humanized mice
X Du, M Liu, J Su, P Zhang, F Tang, P Ye, M Devenport, X Wang, Y Zhang, ...
Cell research 28 (4), 433-447, 2018
1082018
Apoptotic cells induce immunosuppression through dendritic cells: critical roles of IFN-γ and nitric oxide
G Ren, J Su, X Zhao, L Zhang, J Zhang, AI Roberts, H Zhang, G Das, ...
The Journal of Immunology 181 (5), 3277-3284, 2008
832008
p53 regulates mesenchymal stem cell-mediated tumor suppression in a tumor microenvironment through immune modulation
Y Huang, P Yu, W Li, G Ren, AI Roberts, W Cao, X Zhang, J Su, X Chen, ...
Oncogene 33 (29), 3830-3838, 2014
712014
间充质干细胞免疫抑制机制及在疾病中的应用
寿培舜, 黄寅, 苏娟娟, 陈箐, 李文钊, 田新莉, 许光武, 任光文, ...
细胞生物学杂志 31 (1), 15-20, 2009
102009
Established thymic epithelial progenitor/stem cell-like cell lines differentiate into mature thymic epithelial cells and support T cell development
P Chen, J Zhang, Y Zhan, J Su, Y Du, G Xu, Y Shi, U Siebenlist, X Zhang
PloS one 8 (9), e75222, 2013
52013
Soluble CTLA-4 mutants ameliorate immune-related adverse events but preserve efficacy of CTLA-4–and PD-1–targeted immunotherapy
M Liu, X Wang, X Du, W Wu, Y Zhang, P Zhang, C Ai, M Devenport, J Su, ...
Science translational medicine 15 (685), eabm5663, 2023
32023
Genetic and pharmaceutical targeting of HIF1α allows combo-immunotherapy to boost graft vs. leukemia without exacerbation graft vs. host disease
C Bailey, Y Wei, J Yan, D Huang, P Zhang, C Qi, C Lazarski, JJ Su, ...
Cell Reports Medicine 4 (11), 2023
12023
Correction: Established Thymic Epithelial Progenitor/Stem Cell-Like Cell Lines Differentiate into Mature Thymic Epithelial Cells and Support T Cell Development
P Chen, J Zhang, Y Zhan, J Su, Y Du, G Xu, Y Shi, U Siebenlist, X Zhang
Plos one 8 (11), 2013
2013
Translating Stem Cell Research into Patient Care: Hype or Reality?
PD Yufang Shi, Ph.D.*, Xiaodong Chen, B.Med., Liying Zhang, B.Med., Juanjuan ...
The 2011 Sino-American symposium on clinical and translational medicine, 2011
2011
Immunomodulatory properties of mesenchymal stem cells
X HUANG, X HAN, Y HONG, J SU, X TIAN, Q CHEN, W LI, P SHOU, ...
Chinese Bulletin of Life Sciences, 2009
2009
Targeting HIF1α in Bone Marrow Transplant Allows Combo-Immunotherapy to Boost Graft vs Leukemia Effect Without Exacerbation Graft vs Host Disease
C Bailey, Y Wei, J Yan, D Huang, P Zhang, C Qi, CA Lazarski, JJ Su, ...
The system can't perform the operation now. Try again later.
Articles 1–18